Corbus Pharmaceuticals Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Corbus Pharmaceuticals Holdings Inc.
- Former names
- SAV Acquisition Corp
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Norwood
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CRBP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001595097
- EIN
- 46-4348039
Board of directors
-
Alan F. Holmer · DirectorSince 2023
-
Anne Altmeyer · DirectorSince 2023
-
Avery W. Catlin · DirectorSince 2023
-
Brent Pfeiffenberger · DirectorSince 2026
-
John Kenneth Jenkins · DirectorSince 2023
-
Peter Salzmann · DirectorSince 2023
-
Rachelle Suzanne Jacques · DirectorSince 2023
-
Winston Kung · DirectorSince 2024
-
Yong Ben · DirectorSince 2023
-
Yuval Cohen · Director · Chief Executive OfficerSince 2023
Chief executives
Yuval Cohen
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.5%
-
95.7%
-
95.8%
-
99.1%
-
99.1%
-
99.2%
Board connections
4 of this board's directors also sit on 6 other boards.
- via Rachelle Suzanne Jacques
- via Brent Pfeiffenberger
- via Brent Pfeiffenberger
- via Peter Salzmann
- via Winston Kung
- via Rachelle Suzanne Jacques
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $126,241
- 3 purchases by 1 insider
- Sold, last 12 months
- $1,686,584
- 17 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Yong Ben Director | Open-market sale | −2,000 | $7.84 | $15,683 |
| Aug 16, 2026 | Nicacio Leonardo Viana Officer (Chief Medical Officer) | Grant or award | +58,333 | — | — |
| Aug 11, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +2,600 | $9.63 | $25,036 |
| Aug 7, 2026 | Yuval Cohen Director, Officer (Chief Executive Officer) | Open-market sale | −17,000 | $10.08 | $171,396 |
| Aug 7, 2026 | Moran Sean F. Officer (Chief Financial Officer) | Open-market sale | −12,000 | $10.08 | $120,971 |
| Jun 10, 2026 | Winston Kung Director | Open-market sale | −2,026 | $7.91 | $16,026 |
| Jun 10, 2026 | John Kenneth Jenkins Director | Open-market sale | −4,800 | $7.91 | $37,968 |
| Jun 10, 2026 | Anne Altmeyer Director | Open-market sale | −2,412 | $7.91 | $19,079 |
| Jun 3, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +9,000 | $7.58 | $68,220 |
| Jun 2, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +4,500 | $7.33 | $32,985 |
| May 21, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Grant or award | +58,300 | — | — |
| May 19, 2026 | Winston Kung Director | Grant or award | +3,800 | — | — |
| May 19, 2026 | Rachelle Suzanne Jacques Director | Grant or award | +3,800 | — | — |
| May 19, 2026 | John Kenneth Jenkins Director | Grant or award | +3,800 | — | — |
| May 19, 2026 | Anne Altmeyer Director | Grant or award | +3,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.